Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.

Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Weaver DL, Winer E; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Jan;133(1):15-25. doi: 10.1043/1543-2165-133.1.15. No abstract available.

PMID:
19123730
2.

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.

Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, Radvanyi F, Salmon R, Thiery JP, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Delattre O; breast cancer study group of the Institut Curie.

Clin Cancer Res. 2008 Apr 1;14(7):1956-65. doi: 10.1158/1078-0432.CCR-07-1465.

3.

Implications of inconsistent measurement of ER status in non-invasive breast cancer: a study of 1,684 cases from the Sloane Project.

Thomas J, Hanby A, Pinder S, Ellis I, Macartney J, Clements K, Lawrence G, Bishop H; Sloane Project Steering Group.

Breast J. 2008 Jan-Feb;14(1):33-8. doi: 10.1111/j.1524-4741.2007.00523.x.

PMID:
18186863
4.

Immunohistochemical categorisation of ductal carcinoma in situ of the breast.

Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ.

Br J Cancer. 2008 Jan 15;98(1):137-42. Epub 2007 Nov 27.

5.

Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project.

Dodwell D, Clements K, Lawrence G, Kearins O, Thomson CS, Dewar J, Bishop H; Sloane Project Steering Group.

Br J Cancer. 2007 Sep 17;97(6):725-9.

6.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7. Epub 2006 Jun 26.

PMID:
16801628
7.

Impact of a national external quality assessment scheme for breast pathology in the UK.

Ellis IO, Coleman D, Wells C, Kodikara S, Paish EM, Moss S, Al-Sam S, Anderson N, Bobrow L, Buley I, Connolly CE, Dallimore NS, Hales S, Hanby A, Humphreys S, Knox F, Lowe J, Macartney J, Nash R, Parham D, Patnick J, Pinder SE, Quinn CM, Robertson AJ, Shrimankar J, Walker RA, Winder R.

J Clin Pathol. 2006 Feb;59(2):138-45.

8.

An adequate margin of excision in ductal carcinoma in situ.

Kell MR, Morrow M.

BMJ. 2005 Oct 8;331(7520):789-90. No abstract available.

9.

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.

MacDonald HR, Silverstein MJ, Mabry H, Moorthy B, Ye W, Epstein MS, Holmes D, Silberman H, Lagios M.

Am J Surg. 2005 Oct;190(4):521-5.

PMID:
16164913
10.

Trends in the treatment of ductal carcinoma in situ of the breast.

Baxter NN, Virnig BA, Durham SB, Tuttle TM.

J Natl Cancer Inst. 2004 Mar 17;96(6):443-8.

PMID:
15026469
11.

Optimal management of ductal carcinoma in situ of the breast.

Sakorafas GH, Farley DR.

Surg Oncol. 2003 Dec;12(4):221-40. Review.

PMID:
14998563
12.

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.

Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M; UK Coordinating Committee on Cancer Research; Ductal Carcinoma in situ Working Party; DCIS trialists in the UK, Australia, and New Zealand.

Lancet. 2003 Jul 12;362(9378):95-102.

PMID:
12867108
13.

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ.

J Clin Oncol. 2001 Apr 15;19(8):2263-71.

PMID:
11304780
14.

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.

Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA.

Breast Cancer Res Treat. 2000 Aug;62(3):197-210.

PMID:
11072784
15.

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.

de Mascarel I, Bonichon F, MacGrogan G, de Lara CT, Avril A, Picot V, Durand M, Mauriac L, Trojani M, Coindre JM.

Breast Cancer Res Treat. 2000 May;61(2):151-9.

PMID:
10942101
16.

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA.

Lancet. 2000 Feb 12;355(9203):528-33.

PMID:
10683002
17.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N.

Cancer. 1999 Aug 1;86(3):429-38.

PMID:
10430251
18.

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH.

Lancet. 1999 Jun 12;353(9169):1993-2000.

PMID:
10376613
19.

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M.

J Clin Oncol. 1998 Feb;16(2):441-52.

PMID:
9469327
20.

A prognostic index for ductal carcinoma in situ of the breast.

Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN.

Cancer. 1996 Jun 1;77(11):2267-74.

Supplemental Content

Support Center